Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > EBITDA Margin

Amneal Pharmaceuticals Inc EBITDA Margin Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly EBITDA Margin from 2016 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Amneal Pharmaceuticals Inc EBITDA Margin for the quarter ending September 09, 2020 was $18m a -13.75% decrease of -3m year over year
  • Amneal Pharmaceuticals Inc EBITDA Margin for the last 12 months ending September 09, 2020 was $20m a 19.84% increase of 4m year over year
  • Amneal Pharmaceuticals Inc Annual EBITDA Margin for 2019 was $16m a -61.35% decrease of -10m from 2018
  • Amneal Pharmaceuticals Inc Annual EBITDA Margin for 2018 was $26m a -0.57% decrease of 0m from 2017
  • Amneal Pharmaceuticals Inc Annual EBITDA Margin for 2017 was $26m a -14.93% decrease of -4m from 2016
Other Margins & Efficiency Metrics:
  • Amneal Pharmaceuticals Inc Return on Capital % for the quarter ending December 12, 2018 was 4.18 a -281.33% decrease of -11.75 year over year
  • Amneal Pharmaceuticals Inc Return on Equity % for the quarter ending December 12, 2018 was -8.98
View Chart On Koyfin

Quarterly AMRX EBITDA Margin Data

09/2020$18m
06/2020$16m
03/2020$26m
12/2019$21m
09/2019$16m
06/2019$10m
03/2019$18m
12/2018$24m
09/2018$27m
06/2018$24m

Annual AMRX EBITDA Margin Data

2019$16m
2018$26m
2017$26m
2016$30m
2015$29m
2014$31m